We have talked about dropouts in contact lens practice since we started fitting lenses. Jason Nichols, OD, said 16% of contact lens wearers permanently drop out of lens wear each year.1 Many others quote 15-30% of lens wearers drop out each year.
Sjö is a proprietary laboratory test developed by Immco Diagnostics Inc. which combines traditional markers with three novel, proprietary biomarkers, allowing earlier detection of the disease.
Preventing CL dropouts can be a challenge with patients suffering from CLIDE. A number of factors, including the patient’s overall general health, the type of contact lens worn and solution interaction, among others, can influence the condition. Predicting which CL patients are more likely to develop dry eye helps you tailor management to the individual patient needs and set realistic patient goals for successful lens wear.
High pain sensitivity and low pain tolerance appear to be associated with symptoms of dry eye disease, according to a recent study.
The TearScan MicroAssay System (Advanced Tear Diagnostics) enables a clinician to diagnose dry eye or ocular allergy. This in-office, diagnostic platform tests for tear lactoferrin and IgE could also be used for screening patients in advance of refractive surgery or contact lens fits.